Bizarre Patents
Cloaking System Using Optoelectronically Controlled Camouflage
A Cloaking System designed to operate in the visible light spectrum, utilizes optoelectronics and/or photonic components to conceal an object within it.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7754465 | Decontamination of biological agents This invention provides a method for killing biological agents utilizing lime sulfur in liquid or powder form. ... | 07/13/2010 |
| 7485448 | Serum-free medium for producing retroviruses A method for obtaining a virus vector free of a serum, and a serum-free medium for cultivation of a virus producer cell which can be used for the method are provided. By cultivating a virus producer cell using a serum-free medium containing serum albumin, it is poss... | 02/03/2009 |
| 7354593 | Coccidial vaccine and methods of making and using same The present invention relates to a vaccine for coccidiosis in chickens prepared from three attenuated Eimeria species: E. acervulina, E. maxima and E. tenella. The vaccine was similar to or superior to other anticoccidial drugs in stimulating pr... | 04/08/2008 |
| 7319028 | Process for producing sporangia of , control agent, and controlling method The present invention provides a process for efficiently producing sporangia of Bacillus popilliae containing spores and parasporal bodies having controlling effects on Scarabaeidae insects, and a control agent and controlling method for Scarabaeida... | 01/15/2008 |
| 7294491 | Method for producing L-glutamic acid The present invention provides a method for producing L-glutamic acid by fermentation, by culturing in a liquid medium a microorganism that can metabolize a carbon source at a specific pH, and wherein said medium contains a carbon source and L-glutamic acid at a sat... | 11/13/2007 |
| 7235246 | Dermatomycosis vaccine The present invention relates to the preparation of universal inactivated vaccines and their use in preparing compositions for the prophylaxis and therapy of dermatomycosis. Vaccines according to the present invention have the advantage of conferring immunity agains... | 06/26/2007 |
| 7213329 | Method of forming a solder ball on a board and the board In the method, a conductive pad of the board is etched to a depth that is greater than 50% and less than 100% of a thickness of the conductive pad. Subsequently, a solder ball may be formed on the etched conductive pad. For example, the conductive pad may be copper.... | 05/08/2007 |
| 7192754 | -origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same A material and a system are provided that efficiently inactivate a molting hormone by means of a protein having ecdysteroid 22-oxidase activity. ... | 03/20/2007 |
| 7189527 | Bacterial oxidation of sulphide ores and concentrates A process for bacterial oxidation of sulphide ores and concentrates in which the ore or concentrate is leached with a bacterial culture containing one or more strains of both Sulfobacillus and Thermoplasma. ... | 03/13/2007 |
| RE39494 | Inactivated mycoplasma hyopneumoniae and uses therefor The invention relates to a method for making an inactivated vaccine of Mycoplasma hyopneumoniae by inactivating the bacteria with Thimerosal. The resulting bacterin is mixed with an adjuvant of aluminum hydroxide and DEAE dextran and injected into pigs. The r... | 02/27/2007 |
| 7138126 | Transformed A method for modifying a wild strain of an entero-invasive Shigella to produce a modified strain of Shigella that can be used for making a vaccine against the wild strain of Shigella. The genome of the wild strain of Shigella is transform... | 11/21/2006 |
| 7132398 | Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor The present invention provides methods of treating hemorrhagic fevers where selective inhibitors of fVIIa/TF are used as a treatment for hemorrhagic fevers and have therapeutic effects which include ameliorating and/or preventing coagulopathy and inflammatory respon... | 11/07/2006 |
| 7119167 | Fragment of L. lactis plasmid conferring antiphage activity and uses thereof The present invention relates to a 2227-bp DNA fragment that confers antiphage activity. Two proteins encoded by this DNA sequence are responsible for the phage resistance phenotype. When introduced in Lactococcus lactis phage-sensitive strain, this DNA fragm... | 10/10/2006 |
| 7045336 | Bacterial delivery system We describe a bacterial delivery system for the delivery of DNA and antigens into cells. We constructed an attenuated bacterial vector which enters mammalian cells and ruptures delivering functional plasmid DNA and antigens into the cell cytoplasm. This Shigella ... | 05/16/2006 |
| 7022512 | Schizochytrium and thraustochytrium strains for producing high concentrations of omega-3 highly unsaturated fatty acids Disclosed is a process for growing the microflora Thraustochytrium, Schizochytrium, and mixtures thereof, which includes the growing of the microflora in fermentation medium containing non-chloride containing sodium salts, in particular sodium sulfate. In a p... | 04/04/2006 |
| 7011962 | Method of producing lipids by growing microorganisms of the order thraustochyriales Disclosed is a process for growing the microflora Thraustochytrium, Schizochytrium, and mixtures thereof, which includes the growing of the microflora in fermentation medium containing non-chloride containing sodium salts, in particular sodium sulfate. In a p... | 03/14/2006 |
| 7005280 | Method of producing lipids by growing microorganisms of the order thraustochytriales Disclosed is a process for growing the microflora Thraustochytrium, Schizochytrium, and mixtures thereof, which includes the growing of the microflora in fermentation medium containing non-chloride containing sodium salts, in particular sodium sulfate. In a p... | 02/28/2006 |
| 6998127 | Coccidial vaccine and methods of making and using same The present invention relates to a vaccine for coccidiosis in chickens prepared from four attenuated Eimeria species: E. acervulina, E. maxima, E. mitis and E. tenella. The vaccine was similar to or superior to other anticoccidial drugs in stimu... | 02/14/2006 |
| 6984388 | Adhesion deficient isolate of against columnaris disease A safe and effective live vaccine against Flavobacterium columnare of fish was created through the induction of an adhesion deficient isolate of Flavobacterium columnare using a β-lactam antibiotic (ampicillin). Single immersion exposure of fish stimu... | 01/10/2006 |
| 6939705 | Method of protecting La1 against stress A bacterial cell having protection against conditions which are lethal to an unprotected bacterial cell wherein, the protected cell is obtained by subjecting a bacterial cell to treatment with a sublethal level of stress. ... | 09/06/2005 |
| 6916478 | Vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same The invention relates to novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, methods for preparing same, and their use in the prevention and treatment of infectious diseases. ... | 07/12/2005 |
| 6916646 | Enterobacteriaceae fermentation strains Methods are provided for preparing improved fermentation strains of the family Enterobacteriaceae which comprise the steps of eliminating the cryptic plasmid from the progenitor strain thereby creating the improved strain. Methods for reducing the mobilization prope... | 07/12/2005 |
| 6908620 | Coccidial vaccine and methods of making and using same The present invention relates to a vaccine for coccidiosis in chickens prepared from four attenuated Eimeria species: E. acervulina, E. maxima, E. mitis and E. tenella. The vaccine was similar to or superior to other anticoccidial drugs in stimu... | 06/21/2005 |
| 6890542 | Leishmania vaccine The present invention relates to the use of a live mutant Leishmania in the preparation of a vaccine and to vaccine formulations for use in immunizing mammals, such as dogs and/or humans. The mutant Leishmania comprises at least one defective cysteine ... | 05/10/2005 |
| 6787360 | Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof The present invention provides a isolated bacteriophage useful as a tool for studying biological, biochemical, physiological and genetic properties of actinomycetes and other organisms which comprises a novel strain of Saccharomonospora having certain specified char... | 09/07/2004 |
| 6770275 | Live attenuated RTX-producing bacteria of the family pasteurellaceae The present invention relates to live attenuated RTX-toxin producing bacteria of the family Pasteurellaceae, of which the attenuation is due to the fact that they produce RTX toxin in a non-activated form. The invention also relates to vaccines for the protection of... | 08/03/2004 |
| 6759230 | Microbe, microbial exopolysaccharide, and uses thereof A novel microorganism producing a nontoxic, non-antigenic exopolysaccharide is taught. The exopolysaccharide has neutral sugars migrating at the same rate as mannose, fucose, fructose and galactose, acidic sugars migrating at the same rate as fucose and amine sugars... | 07/06/2004 |
| 6682914 | Bioactive tetracyclic diterpene compounds and methods of preparation and use thereof Newly-isolated and purified metabolites which are effective in regulating the development of at least one filamentous fungal microorganism species are disclosed. These compounds, which are referred to as conidiogenol and conidiogenone, may be used to indu... | 01/27/2004 |
| 6653135 | Dynamic protein signature assay An assay to determine the specific expression and suppression of proteins in response to a stressor is disclosed. An organism exposed to a stressor, including disease caused by exposure to, e.g., a parasite, or a substance suspected of causing an adverse ... | 11/25/2003 |
| 6593087 | Methods for detecting and reversing resistance to macrocyclic lactone compounds This invention describes novel purified and isolated nucleic acid molecules or the fragments thereof, extracted from nematode or arthropod pests or recombinant, which encode P-glycoprotein homologs and regulate resistance to the macrocyclic lactone compou... | 07/15/2003 |
| 6589771 | Methods for arousing dormant bacteria A method for arousing dormant bacteria. The method comprises inducing diffusion of intracellular solutes from dormant bacteria and then allowing an adjustment period for a length of time sufficient to initiate arousal. The decrease in intracellular osmola... | 07/08/2003 |
| 6534054 | Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived materia... | 03/18/2003 |
| 6514494 | Bacterial strain, processed plant extracts, compostions containing same, processes for their preparation and their therapeutic and industrial applications The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived materia... | 02/04/2003 |
| 6410021 | Vaccines of pasteurellaceae mutants and vaccination method A live vaccine of recombinant mutants of a member of the family Pasteurellaceae lacking a rib gene necessary for production of riboflavin as well as a method of vaccination therewith is described. The vaccine is effective against members of the family Pas... | 06/25/2002 |
| 6410012 | Antimicrobial mediated bacterial DNA delivery This invention pertains in part to a method for delivering functional DNA or antigens. The desired DNA is introduced into attenuated bacteria able to enter cells. Once the bacteria is in the cell, antimicrobial agents are introduced such that they enter t... | 06/25/2002 |
| 6410265 | Gene encoding a putive efflux protein for solvents/antibiotics in Pseudomonas mendocina This invention relates to the isolation of a novel putative efflux gene from Pseudomonas mendocina. The putative efflux gene is useful for probing an organism's efflux system to gain an understanding of the mechanisms of solvent tolerance. The invention f... | 06/25/2002 |
| 6376245 | Associations of antagonistic prokaryotes with eukaryotes The invention provides a process for protecting whole eukaryotes or parts thereof from an invasive attack from an invasive agent which comprises, selecting a prokaryotic bacterium which is capable of forming an L-form association with a host eukaryote and... | 04/23/2002 |
| 6376228 | Heterophil-adapted poultry vaccine A method for vaccinating poultry to prevent salmonellosis and other microbial-related health problems in humans is described. The method involves isolation of a poultry heterophil-adapted strain of a microorganism that may be used in a vaccine. A vaccine ... | 04/23/2002 |
| 6350608 | Biological digestion of animal carcasses A process is provided for the biological digestion of animal carcasses. First, the carcass is cut into smaller pieces with equipment that masticates, grinds or comminutes in the presence of water to create a solid-liquid mixture. The next steps include tr... | 02/26/2002 |
| 6323025 | In vitro cell culture in media containing beta-alanyl-taurine or carbobenzoxy beta-alanyl-taurine Compounds termed "vitaletheine modulators" which include beta-alanyl-taurine and carbobenzoxy beta-alanyl-taurine are synthesized and added to culture media for in vitro culture of cells such as mammalian or plant cells. The compounds support cell vitalit... | 11/27/2001 |
